AVP and cerebral infarction: In the escitalopram treatment group, the NIHSS and HAMD scores significantly decreased, the incidence of PSD significantly decreased, the BI significantly increased, and the plasma copeptin levels significantly decreased, compared to patients treated with routine therapies for cerebral infarction, which is consistent with some previous research results (4-7).